DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignanciesSimone C. Oostindie, Esther C.W. Breij, Martine E.D. Chamuleau et al.|Blood Cancer Journal|2020Cited by 70